Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | CDK1 | P06493 | 1/20 | 0.57 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.57 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | AMY2A | P04746 | 2/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.44 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13156776 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL13904361 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL21356838 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| SCHEMBL20226190 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL3192294 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL24013212 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL21114348 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL21356841 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL21356840 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| SCHEMBL19131299 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117258036-A | Bone-like bioactive polycaprolactone porous scaffold and preparation method thereof | 广东瑞程医学科技有限公司 | 2023-12-22 | — | — | CN | claimed |
| US-20190281874-A1 | OLIGOSACCHARIDES FOR FLAVOUR GENERATION | Société des Produits Nestlé S.A. (CH) | 2019-09-19 | — | — | US | claimed |
| US-20130171705-A1 | NOVEL LACTIC ACID BACTERIUM AND METHOD FOR PRODUCING L-LACTIC ACID USING SAME | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2013-07-04 | — | — | US | claimed |
| EP-1847270-B1 | USE OF AMYGDALIN ANALOGUES FOR THE TREATMENT OF PSORIASIS | UNIV CATALUNYA POLITECNICA (ES) | 2010-03-03 | — | — | EP | claimed |
| US-20080125378-A1 | Use of Amygdalin Analogues for the Treatment of Psoriasis | UNIVERSITAT POLITECNICA DE CATALUNYA (ES) | 2008-05-29 | — | — | US | claimed |
| EP-1847270-A1 | USE OF AMYGDALIN ANALOGUES FOR THE TREATMENT OF PSORIASIS | Universitat Politecnica de Catalunya (ES) | 2007-10-24 | — | — | EP | claimed |
| CN-117258036-B | Bone-like bioactive polycaprolactone porous scaffold and preparation method thereof | 广东瑞程医学科技有限公司 | 2026-05-01 | — | — | CN | disclosed |
| CN-117258036-A | Bone-like bioactive polycaprolactone porous scaffold and preparation method thereof | 广东瑞程医学科技有限公司 | 2023-12-22 | — | — | CN | disclosed |
| CN-117258036-A | Bone-like bioactive polycaprolactone porous scaffold and preparation method thereof | 广东瑞程医学科技有限公司 | 2023-12-22 | — | — | CN | disclosed |
| US-20190281874-A1 | OLIGOSACCHARIDES FOR FLAVOUR GENERATION | Société des Produits Nestlé S.A. (CH) | 2019-09-19 | — | — | US | disclosed |
| EP-2361282-B1 | HEAVY METAL-FREE STABILIZER COMPOSITION FOR HALOGENATED POLYMERS | CHEMSON POLYMER-ADDITIVE AG (AT) | 2018-02-21 | — | — | EP | disclosed |
| EP-1999137-B1 | SYNTHETIC ARCHAEAL GLYCOLIPID ADJUVANTS | NAT RES COUNCIL CANADA (CA) | 2016-03-30 | — | — | EP | disclosed |
| US-9234219-B2 | Method for producing L-lactic acid by lactic acid bacterium under presence of pentose and cellooligosaccharides | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2016-01-12 | — | — | US | disclosed |
| EP-1847270-A1 | USE OF AMYGDALIN ANALOGUES FOR THE TREATMENT OF PSORIASIS | Universitat Politecnica de Catalunya (ES) | 2007-10-24 | — | — | EP | disclosed |
| WO-2007112567-A1 | SYNTHETIC ARCHAEAL GLYCOLIPID ADJUVANTS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2007-10-11 | — | — | WO | disclosed |
| US-7118895-B2 | Process for producing aglycon by using diglycosidase and flavor-improved food containing the aglycon and converting agent to be used in the process | AMANO ENZYME INC. (JP) | 2006-10-10 | — | — | US | disclosed |
| US-20060216281-A1 | Process for producing aglycon and flavor-improved food containing the aglycon by diglycosidase, and converting agent to be used in the process | AMANO ENZYME INC. | 2006-09-28 | — | — | US | disclosed |
| US-20030194469-A1 | Process for producing aglycon by using diglycosidase and flavor-improved food containing the aglycon and converting agent to be used in the process | AMANO ENZYME INC. (JP) | 2003-10-16 | — | — | US | disclosed |
| EP-1270735-A1 | PROCESS FOR PRODUCING AGLYCON BY USING DIGLYCOSIDASE AND FLAVOR-IMPROVED FOOD CONTAINING THE AGLYCON AND CONVERTING AGENT TO BE USED IN THE PROCESS | Amano Enzyme Inc. (JP) | 2003-01-02 | — | — | EP | disclosed |
| EP-0404964-B1 | PRODUCTION OF SUGAR COMPOUNDS | SHOWA DENKO KK (JP) | 1994-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080125378-A1 | Use of Amygdalin Analogues for the Treatment of Psoriasis | C3AR1, CCR7, C5AR1 | GAA 4148/4885CA2 1390/4885CDK1 433/4885 |
| US-20060216281-A1 | Process for producing aglycon and flavor-improved food containing the aglycon by diglycosidase, and converting agent to be used in the process | GAA, SI, MGAM | GAA 1/4885CA2 169/4885CDK1 2914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.